Evolution and function of the ADP ribosyl cyclase/CD38 gene family in physiology and pathology

Cited by (866)

Items 501–600 of 866

1. Isatuximab-pomalidomide-dexamethasone versus pomalidomide-dexamethasone in patients with relapsed and refractory multiple myeloma: final overall survival analysis
   Paul Gerard Guy Richardson, Aurore Perrot, Jesús F. San Miguel, Meral Beksaç, Ivan Špıčka, Xavier P Leleu, Fredrik Hellem Schjesvold, Philippe Moreau, Meletios Athanasios Dimopoulos, Shang‐Yi Huang et al. · 2024 · Haematologica
2. A Molecular Perspective and Role of NAD+ in Ovarian Aging
   Mehboob Ahmed, Umair Riaz, Haimiao Lv, Liguo Yang · 2024 · International Journal of Molecular Sciences
3. Mitonuclear Communication in Stem Cell Function
   Baozhou Peng, Yaning Wang, Hongbo Zhang · 2024 · Cell Proliferation
4. Identification of structural determinants of nicotinamide phosphoribosyl transferase (NAMPT) activity and substrate selectivity
   Dorothée Houry, Arne Raasakka, Eugenio Ferrario, Marc Niere, Ersilia Bifulco, Petri Kursula, Mathias Ziegler · 2023 · Journal of Structural Biology
5. Which therapies will move to the front line for multiple myeloma?
   María José Cejalvo, Javier de la Rubia · 2017 · Expert Review of Hematology
6. Conformational Closure of the Catalytic Site of Human CD38 Induced by Calcium
   Qun Liu, Richard Milton Graeff, Irina A. Kriksunov, Connie Mo Ching Lam, Hon Cheung Lee, Quan Hao · 2008 · Biochemistry
7. Myeloid but not hepatocytic CD38 is a key driver for hepatic ischemia/reperfusion injury
   Qi‐Hang Zhao, Yating Zhang, Ke Wen, Qi Ding, Ziying Chen, Dilinuer Tula, Jia-Hui Li, Juan Zhou, Yun‐Fei Xiao, Xiao‐Hui Guan et al. · 2025 · Signal Transduction and Targeted Therapy
8. Targeting NAD+ Metabolism: Preclinical Insights into Potential Cancer Therapy Strategies
   Ayca Nazli Mogol, Alanna Zoe Kaminsky, David J Dutton, Zeynep Madak‐Erdogan · 2024 · Endocrinology
9. Pathways to therapy resistance: The sheltering effect of the bone marrow microenvironment to multiple myeloma cells
   Kuntal Bhowmick, Max Von Suskil, Omar S. Al‐Odat, Weam Othman Elbezanti, Subash C. Jonnalagadda, Tülin Budak-Alpdoǧan, Manoj Kumar Pandey · 2024 · Heliyon
10. CD38 Coordinates with NF-κB to Promote Cochlear Inflammation in Noise-Induced Hearing Loss: the Protective Effect of Apigenin
    Da Liu, Na Sai, Ying Zhou, Ning Yu, Qing‐qing Jiang, Wei Sun, Wei-ju Han, Weiwei Guo · 2024 · Molecular Neurobiology
11. Pharmacokinetics and pharmacodynamics of the cytolytic anti‐ CD 38 human monoclonal antibody TAK ‐079 in monkey – model assisted preparation for the first in human trial
    Stefan Roepcke, Nele Plock, Josh J. Yuan, Eric Robert Fedyk, Gëzim Lahu, Lin Zhao, Glennda M. Smithson · 2018 · Pharmacology Research & Perspectives
12. Second COVID-19 infection in a patient with multiple myeloma in Brazil – reinfection or reactivation?
    Marcelo Bellesso, Felipe Ribeiro Bruniera, Ariel Testasicca Trunkel, Izabel Pernambuco Nicodemo · 2020 · Hematology Transfusion and Cell Therapy
13. A Bright Horizon: Immunotherapy for Pediatric T-Cell Malignancies
    Haley M. Newman, David T. Teachey · 2022 · International Journal of Molecular Sciences
14. Plasma Cell Directed Therapy for Immune Thrombotic Thrombocytopenic Purpura (iTTP)
    Melissa Chen, Jake Shortt · 2022 · Transfusion Medicine Reviews
15. The adenosinergic machinery in cancer: In-tandem insights from basic mechanisms to therapy
    Chifei Kang, Luyu Liu, Cheng‐Yu Wu, Lingyun Li, Jia Xiao, Wendi Xie, Siyu Chen, Xinying Wu, Huaxiao Zheng, Jingxin Liu et al. · 2023 · Frontiers in Immunology
16. Chronic Hepatitis C Virus Infection and the Proinflammatory Effects of Injection Drug Use
    Martin H. Markowitz, Sherry Deren, Charles M. Cleland, Melissa La Mar, Evelyn Silva, Pedro Batista, Leslie St. Bernard, Natanya Gettie, Kristina Rodriguez, Teresa H. Evering et al. · 2016 · The Journal of Infectious Diseases
17. Practical Considerations in Managing Relapsed Multiple Myeloma
    Amit Agarwal, Eric Chow, Manisha Bhutani, Peter Michael Voorhees, Reed N. Friend, Saad Z. Usmani · 2016 · Clinical Lymphoma Myeloma & Leukemia
18. Antibody mimicry, receptors and clinical applications
    Alberto L. Horenstein, Antonella Chillemi, Valeria Quarona, Andrea Zito, Valentina Mariani, Angelo Corso Faini, Fabio Morandi, Ilaria Schiavoni, Clara Maria Ausiello, Fabio Malavasi · 2016 · Human Antibodies
19. Monoclonal Antibodies versus Histone Deacetylase Inhibitors in Combination with Bortezomib or Lenalidomide plus Dexamethasone for the Treatment of Relapsed or Refractory Multiple Myeloma: An Indirect-Comparison Meta-Analysis of Randomized Controlled Trials
    Yanhua Zheng, Hong-Yuan Shen, Li Xu, Juan Feng, Hailong Tang, Na Zhang, Xiequn Chen, Guangxun Gao · 2018 · Journal of Immunology Research
20. Inflammatory cell expression of Toll-like receptor-2 (TLR2) within refractory periapical granuloma.
    Eric Chen, Mahmoud M. Bakr, Norman A. Firth, Robert Matthew Love · 2018 · F1000Research
21. Preliminary Evidence That CD38 Moderates the Association of Neuroticism on Amygdala-Subgenual Cingulate Connectivity
    Benjamin A. Tabak, Katherine Seaton Young, Jared B. Torre, Baldwin M. Way, Lisa J. Burklund, Naomi I. Eisenberger, Matthew D. Lieberman, Michelle G. Craske · 2020 · Frontiers in Neuroscience
22. Risks and rewards of targeting NAD+ homeostasis in the brain
    Catherine Li, Lindsay E. Wu · 2021 · Mechanisms of Ageing and Development
23. CD38 is Required for Dendritic Organization in Visual Cortex and Hippocampus
    Thom P. Nelissen, Rosemary A. Bamford, Shiro Tochitani, Kamuran Akkus, Aurimas Kudzinskas, Kenichiro Yokoi, Hiroshi Okamoto, Yasuhiko Yamamoto, J. Peter H. Burbach, Hideo Matsuzaki et al. · 2018 · Neuroscience
24. CD38-Induced Metabolic Dysfunction Primes Multiple Myeloma Cells for NAD+-Lowering Agents
    Pamela Becherini, Debora Soncini, Silvia Ravera, Elisa Gelli, Claudia Martinuzzi, Giulia Giorgetti, Antonia Cagnetta, Fabio Guolo, Federico Ivaldi, Maurizio Miglino et al. · 2023 · Antioxidants
25. Genetic polymorphisms of bone marrow stromal cell antigen-1 (BST-1/CD157): implications for immune/inflammatory dysfunction in neuropsychiatric disorders
    Shigeru Yokoyama · 2023 · Frontiers in Immunology
26. Heavy-chain antibody targeting of CD38 NAD+ hydrolase ectoenzyme to prevent fibrosis in multiple organs
    Bo Shi, Asif Amin, Pranjali Dalvi, Wenxia Wang, Nicholas W. Lukacs, Li Kai, Paul Cheresh, Thais Peclat, Claudia C.S. Chini, Eduardo N. Chini et al. · 2023 · Scientific Reports
27. LLT1 overexpression renders allogeneic-NK resistance and facilitates the generation of enhanced universal CAR-T cells
    Shuxian Zhu, Shiyu Zuo, Chuo Li, Xingjie You, Erlie Jiang, Xiaoxue Feng, Yuechen Luo · 2025 · Journal of Experimental & Clinical Cancer Research
28. Daratumumab and its Use in the Treatment of Relapsed and/or Refractory Multiple Myeloma
    Sarah Chehab, Elyse Hall Panjic, Charise L. Gleason, Sagar Lonial, Ajay K. Nooka · 2018 · Future Oncology
29. CD38 as a multifaceted immunotherapeutic target in CLL
    Aneel Paulus, Fabio Malavasi, Asher Alban Chanan-Khan · 2022 · Leukemia & lymphoma/Leukemia and lymphoma
30. Bone marrow stromal cell antigen-1 (CD157) regulated by sphingosine kinase 2 mediates kidney fibrosis
    Tsuyoshi Inoue, Yasuna Nakamura, Shinji Tanaka, Takahide Kohro, Lisa X. Li, Liping Huang, Junlan Yao, Suzuka Kawamura, Reiko Inoue, Hiroshi Nishi et al. · 2022 · Frontiers in Medicine
31. Nicotinamide Adenine Dinucleotide (NAD + )-Dependent Signaling in Neurological Disorders
    Mariana Bresque, Daniel Esteve, Mariana Pehar, Marcelo R. Vargas · 2023 · Antioxidants and Redox Signaling
32. CD38 x ICAM-1 Bispecific Antibody Is a Novel Approach for Treating Multiple Myeloma and Lymphoma
    Xiaocheng Chen, Oi Kwan Wong, Lauren T. Reiman, Daniel W. Sherbenou, Leonard E. Post · 2023 · Molecular Cancer Therapeutics
33. ADP ribosyl-cyclases (CD38/CD157), social skills and friendship
    Anne Chong, Fabio Malavasi, Salomon Israel, Chiea Chuen Khor, Von Bing Yap, Mikhail V. Monakhov, Soo Hong Chew, Poh San Lai, Richard P. Ebstein · 2017 · Psychoneuroendocrinology
34. Functional insights into nucleotide-metabolizing ectoenzymes expressed by bone marrow-resident cells in patients with multiple myeloma
    Alberto L. Horenstein, Fabio Morandi, Cristiano Bracci, Vito Pistoia, Fabio Malavasi · 2018 · Immunology Letters
35. TPC2-mediated Ca2+ signaling is required for axon extension in caudal primary motor neurons in zebrafish embryos
    Chenxi Guo, Sarah Webb, Ching Man Chan, Andrew L. Miller · 2020 · Journal of Cell Science
36. Neurophysiological functions and pharmacological tools of acidic and non-acidic Ca2+ stores
    Lora L. Martucci, José‐Manuel Cancela · 2022 · Cell Calcium
37. Expression of CD38 with intracellular enzymatic activity: a possible explanation for the insulin release induced by intracellular cADPR
    Yasuhiko Ohta, Akira Kitanaka, Keichiro Mihara, Osamu Imataki, Hiroaki Ohnishi, Terukazu Tanaka, Tomohiko Taminato, Yoshitsugu Kubota · 2011 · Molecular and Cellular Biochemistry
38. Large changes in NAD levels associated with CD38 expression during HL-60 cell differentiation
    Zainab N. Al-Abady, Barbara Durante, A. John Moody, Richard A. Billington · 2013 · Biochemical and Biophysical Research Communications
39. The Identification of a Novel Calcium-Dependent Link Between NAD+ and Glucose Deprivation-Induced Increases in Protein O-GlcNAcylation and ER Stress
    Luyun Zou, Helen E. Collins, Martin Elliot Young, Jianhua Zhang, Adam R. Wende, Victor M. Darley-Usmar, John C. Chatham · 2021 · Frontiers in Molecular Biosciences
40. Premature senescence and cardiovascular disease following cancer treatments: mechanistic insights
    Ashita Jain, Diego Casanova, Alejandra Valdivia Padilla, Angelica Paniagua-Bojorges, Sivareddy Kotla, Kyung Ae Ko, Venkata Subrahman K Samanthapudi, Khanh Minh Chau, Minh Thi Nguyen, Jake Jianjun Wen et al. · 2023 · Frontiers in Cardiovascular Medicine
41. Impending HCC diagnosis in patients with cirrhosis after HCV cure features a natural killer cell signature
    Sophie Anna Engelskircher, Po-Chun Chen, Benedikt Strunz, Carlos Oltmanns, Tijana Ristic, Solomon Owusu Sekyere, Anke R.M. Kraft, Markus Cornberg, Thomas Christian Wirth, Bernd Heinrich et al. · 2024 · Hepatology
42. The new insight into extracellular NAD+ degradation‐the contribution of CD38 and CD73 in calcific aortic valve disease
    Patrycja Jabłońska, Barbara Anna Kutryb-Zając, Paulina Mierzejewska, Agnieszka Jasztal, Barbara Bocian, Romuald Lango, Jan A. Rogowski, Stefan Chłopicki, Ryszard Tomasz Smolenski, Ewa Maria Slominska · 2021 · Journal of Cellular and Molecular Medicine
43. The role of NAD+ metabolism in macrophages in age-related macular degeneration
    Ruoyi Lin, Jing Yu · 2022 · Mechanisms of Ageing and Development
44. Base-Exchange Enabling the Visualization of SARM1 Activities in Sciatic Nerve-Injured Mice
    Ke Huang, Wenjie Zhu, Wan Hua Li, Hon Cheung Lee, Yong Juan Zhao, Chi‐Sing Lee · 2023 · ACS Sensors
45. Unsupportive social interactions and affective states: examining associations of two oxytocin-related polymorphisms
    Opal Arilla McInnis, Robyn Jane McQuaid, Kimberly Matheson, Hymie Anisman · 2017 · Stress
46. Why Immunotherapy Fails in Multiple Myeloma
    Luis Gerardo Rodríguez‐Lobato, Aina Oliver‐Caldés, David Fernando Moreno, Carlos Fernández de Larrea, Joan Bladé · 2020 · Hemato
47. Preclinical characterization of a novel investigational monoclonal antibody CM313 with potent CD38-positive cell killing activity
    Wei Liu, Juntao Yu, Kaiwen Sun, Qin Song, Yuling Li, Yanyun He, Yanrong Wang, Gang Xu, Changyu Wang, Bo Chen · 2024 · Frontiers in Immunology
48. Nicotinamide N-methyltransferase in cardiovascular Diseases: Mechanistic insights and therapeutic potential
    Shuang-Zhou Bi, Wei-Dong Sun, Xiaojuan Zhu, Shi-Yan Lai, An-Liu, Chen-Ying Zhang, Jiang-Hua Li · 2025 · European Journal of Medicinal Chemistry
49. Cell Type–Specific Roles of CD38 in the Interactions of Isoniazid with NAD+ in the Liver
    Junjie Zhu, Jie Li Lu, Hung‐Chun Tung, Ke Liu, Jianhua Li, Denis M. Grant, Wen Xie, Xiaochao Ma · 2020 · Drug Metabolism and Disposition
50. Role of CD38 in Adipose Tissue: Tuning Coenzyme Availability?
    Andrea Benzi, Alessia Grozio, Sonia Spinelli, Laura Sturla, Andreas H. Guse, Antonio DE FLORA, Elena Zocchi, Jöerg Heeren, Santina Bruzzone · 2021 · Nutrients
51. SEPTIN2 and STATHMIN Regulate CD99-Mediated Cellular Differentiation in Hodgkin's Lymphoma
    Wenjing Jian, Lin Zhong, Jing Wen, Yao Tang, Bo Qiu, Ziqing Wu, Jinhai Yan, Xinhua Zhou, Tong Zhao · 2015 · PLoS ONE
52. Phenobarbital Induces Alterations in the Proteome of Hepatocytes and Mesenchymal Cells of Rat Livers
    Philip Klepeisz, Sandra Sagmeister, Verena J. Haudek‐Prinz, Melanie Pichlbauer, Bettina Grasl‐Kraupp, Christopher Gerner · 2013 · PLoS ONE
53. RNA-based markers as prognostic factors in chronic lymphocytic leukemia
    Marie Sevov, Richard Rosenquist, Larry Mansouri · 2012 · Expert Review of Hematology
54. High-fat-diet induces airway hyperresponsiveness partly through activating CD38 signaling pathway
    Lei Chong, Weixi Zhang, Gang Yu, Hailin Zhang, Lili Zhu, Haiyan Li, Youyou Shao, Changchong Li · 2018 · International Immunopharmacology
55. Soluble CD157 in pleural effusions: a complementary tool for the diagnosis of malignant mesothelioma
    Stefania Augeri, Stefania Capano, Simona Morone, Giulia Fissolo, Alice Giacomino, Silvia Peola, Zahida Drače, Ida Rapa, Silvia Novello, Marco Volante et al. · 2018 · Oncotarget
56. Novel Immunotherapeutic Agents for the Treatment of Multiple Myeloma
    Hind Rafei, Faysal Haroun, Imad A. Tabbara · 2018 · American Journal of Clinical Oncology
57. A comprehensive overview of daratumumab and carfilzomib and the recently approved daratumumab, carfilzomib and dexamethasone regimen in relapsed/refractory multiple myeloma
    Shambavi Richard, Sundar Jagannath, Hearn Jay Cho, Samir Sunil Parekh, Deepu Madduri, Joshua Ryan Richter, Ajai Chari · 2020 · Expert Review of Hematology
58. Identification of ADP-ribosylation sites of CD38 mutants by precursor ion scanning mass spectrometry
    Hong Jiang, Robert Sherwood, Sheng Zhang, Xuling Zhu, Qun Liu, Richard Milton Graeff, Irina A. Kriksunov, Hon Cheung Lee, Quan Hao, Hening Lin · 2012 · Analytical Biochemistry
59. CD38 Ligation in Peripheral Blood Mononuclear Cells of Myeloma Patients Induces Release of Protumorigenic IL-6 and Impaired Secretion of IFNγCytokines and Proliferation
    Giorgio Fedele, Marco Di Girolamo, Umberto Recine, Raffaella Palazzo, Francesca Urbani, Alberto L. Horenstein, Fabio Malavasi, Clara Maria Ausiello · 2013 · Mediators of Inflammation
60. Cyclic ADP Ribose-Dependent Ca2+ Release by Group I Metabotropic Glutamate Receptors in Acutely Dissociated Rat Hippocampal Neurons
    Jong‐Woo Sohn, Weonjin Yu, Doyun Lee, Hee‐Sup Shin, Suk‐Ho Lee, Won‐Kyung Ho · 2011 · PLoS ONE
61. Ectonucleotidases in Immunobiology
    Luiz Eduardo Baggio Savio, Marco De Giorgi, Simon Christopher Robson · 2016 · Elsevier eBooks
62. Interleukin-27-polarized HIV-resistant M2 macrophages are a novel subtype of macrophages that express distinct antiviral gene profiles in individual cells: implication for the antiviral effect via different mechanisms in the individual cell-dependent manner
    Tomozumi Imamichi, Jun Yang, Qian Chen, Suranjana Goswami, Mayra Marquez, Udeshika Kariyawasam, Homa Nath Sharma, Rosana A. Wiscovitch-Russo, Xuan Li, Akihiro Aioi et al. · 2025 · Frontiers in Immunology
63. Paracrine ADP Ribosyl Cyclase-Mediated Regulation of Biological Processes
    Cecilia Astigiano, Andrea Benzi, Maria Elena Laugieri, Francesco Piacente, Laura Sturla, Lucrezia Guida, Santina Bruzzone, Antonio DE FLORA · 2022 · Cells
64. Mechanism of CD38 via NAD + in the Development of Non-alcoholic Fatty Liver Disease
    Min Dong, Shuo Wang, Zuowei Pei · 2023 · International Journal of Medical Sciences
65. Bone marrow stromal cell antigen-1 deficiency protects from acute kidney injury
    Tsuyoshi Inoue, Ryusuke Umene, Sun‐Sang J. Sung, Shinji Tanaka, Liping Huang, Junlan Yao, Noritatsu Hashimoto, Chia-Hsien Wu, Yasuna Nakamura, Tomoya Nishino et al. · 2023 · American Journal of Physiology-Renal Physiology
66. Targeting CD38/ ADP-ribosyl cyclase as a novel therapeutic strategy for identification of three potent agonists for leukopenia treatment
    Yuanzhi Liu, Linwei Zhang, Long Wang, Xiaoqin Tang, Shengli Wan, Qianqian Huang, Mei Ran, Hongping Shen, Yan Yang, Sawitree Chiampanichayakul et al. · 2024 · Pharmacological Research
67. Oxytocin transported from the blood across the blood-brain barrier by receptor for advanced glycation end-products (RAGE) affects brain function related to social behavior
    Haruhiro Higashida, Yu Oshima, Yasuhiko Yamamoto · 2024 · Peptides
68. CD38 Deficiency Protects Mouse Retinal Ganglion Cells Through Activating the NAD+/Sirt1 Pathway in Ischemia-Reperfusion and Optic Nerve Crush Models
    Yulian Pang, Haijian Hu, Ke Xu, Ting Cao, Zhiruo Wang, Jiahe Nie, Haina Zheng, Hongdou Luo, Feifei Wang, Chan Xiong et al. · 2024 · Investigative Ophthalmology & Visual Science
69. Novel therapeutic targets in Waldenstrom macroglobulinemia
    Aneel Paulus, Sikander Ailawadhi, Asher Alban Chanan-Khan · 2016 · Best Practice & Research Clinical Haematology
70. Monoclonal antibodies as an addition to current myeloma therapy strategies
    Maxime Jullien, Cyrille Touzeau, Philippe Moreau · 2020 · Expert Review of Anticancer Therapy
71. Extracellular Vesicles in Cancer Progression: Are They Part of The Problem or Part of The Solution?
    Juliete Nathali Scholl, Camila Kehl Dias, Laurent Müller, Ana Maria Oliveira Battastini, Fabrício Figueiró · 2020 · Nanomedicine
72. Tricyclodecan-9-yl-Xanthogenate (D609): Mechanism of Action and Pharmacological Applications
    Aashiq Hussain Bhat, Khalid Bashir Dar, Andleeb Khan, Saeed Alshahrani, Sultan Alshehri, Mohammed M. Ghoneim, Prawez Alam, Faiyaz Shakeel · 2022 · International Journal of Molecular Sciences
73. Elevated CD38 expression characterizes impaired CD8+ T cell immune response in metastatic pleural effusions
    Yaoxin Zhang, Wenhui Li, Kaili Ma, Jiawei Zhai, Yujia Jin, Lianjun Zhang, Cheng Chen · 2022 · Immunology Letters
74. Identification of Genetic Variations in the NAD-Related Pathways for Patients with Major Depressive Disorder: A Case-Control Study in Taiwan
    Daniel Tzu-Li Chen, Szu‐Wei Cheng, Tiffany Chen, Jane Pei‐Chen Chang, Bing‐Fang Hwang, Hen‐Hong Chang, Eric Y. Chuang, Che‐Hong Chen, Kuan‐Pin Su · 2022 · Journal of Clinical Medicine
75. Extracellular Adenosine Diphosphate Ribose Mobilizes Intracellular Ca2+ via Purinergic-Dependent Ca2+ Pathways in Rat Pulmonary Artery Smooth Muscle Cells
    Chun Huang, Jinxing Hu, Krishna Prasad Subedi, Amanda H.Y. Lin, Omkar Paudel, Pixin Ran, James S.K. Sham · 2015 · Cellular Physiology and Biochemistry
76. Preferential Coupling of the NAADP Pathway to Exocytosis in T-Cells
    Lianne C. Davis, Frances M. Platt, Anthony Galione · 2015 · Messenger
77. The diagnostic and prognostic value of CD38 and CD49d expressions in chronic lymphocytic leukemia
    OlfatM Hendy, Mona Al Shafie, Maha Allam, Tawfik Abdel Motalib, Fatma A. Khalaf, Suzy Fawzy Gohar · 2016 · The Egyptian Journal of Haematology
78. New drugs in early development for treating multiple myeloma: all that glitters is not gold
    Luca Bertamini, Francesca Bonello, Mario Boccadoro, Sara Bringhen · 2020 · Expert Opinion on Investigational Drugs
79. Progression of Kidney Fibrosis after Sepsis
    Charles de Roquetaillade, Manon Durand, Victor Beaucoté, Jérémie Guillemin, Christos Evangelos Chadjichristos, Antoine Roquilly, Benjamin Glenn Chousterman · 2025 · Journal of the American Society of Nephrology
80. CD38 ‐Targeting Peptide Vaccine Ameliorates Aging‐Associated Phenotypes in Mice
    Shangcheng Yu, LI Zhi-qiang, Yuxiang Tang, Yu‐Ling Chen, Yingying Ma, Kunlin Du, Zhaoyun Zong, Kangze Feng, Yali Wei, Limeng Chen et al. · 2025 · Aging Cell
81. Therapeutic Options for Patients with TP53 Deficient Chronic Lymphocytic Leukemia: Narrative Review
    Paulina Stefaniuk, Julia Onyszczuk, Agnieszka Szymczyk, Monika Podhorecka · 2021 · Cancer Management and Research
82. Integrated bioinformatic analyses investigate macrophage-M1-related biomarkers and tuberculosis therapeutic drugs
    Siqi Deng, Shijie Shen, Keyu Liu, Saeed A. El-Ashram, Abdulaziz Alouffi, Beniamino Terzo Cenci-Goga, Guomin Ye, Chengzhang Cao, Tingting Luo, Hui Zhang et al. · 2023 · Frontiers in Genetics
83. CD38 deficient mice are not protected from atherosclerosis
    Xiang Yi Kong, Knut Husø Lauritzen, Tuva Børresdatter Dahl, Sverre Holm, Maria Belland Olsen, Mona Skjelland, Christopher Sivert Nielsen, Annika Elisabet Michelsen, Thor Ueland, Pål Aukrust et al. · 2024 · Biochemical and Biophysical Research Communications
84. Investigating Vα7.2+/CD161− T Cell and MAIT Cell Profiles Using Flow Cytometry in Healthy Subjects and Subjects with Atopic Dermatitis
    Parvind Singh, Krisztián Gáspár, Andrea Szegedi, László Sajtos, Sándor Baráth, Zsuzsanna Hevessy · 2024 · International Journal of Molecular Sciences
85. From gene modules to gene markers: an integrated AI-human approach selects CD38 to represent plasma cell-associated transcriptional signatures
    Basirudeen Syed Ahamed Kabeer, Bishesh Subba, Darawan Rinchai, Mohammed Toufiq, Taushif Khan, Marina Yurieva, Damien Chaussabel · 2025 · Frontiers in Medicine
86. Heterogeneous CD38 expression in tumor tissues of patients with colorectal cancer
    Alexey D. Perenkov, Д. В. Новиков, Сахарнов Николай Александрович, Anna V. Alyasova, Oleg Vladimirovich Utkin, Anatoly Yu. Baryshnikov, Novikov Vv · 2012 · Molecular Biology
87. Detection of Human CD38 Using Variable Lymphocyte Receptor (VLR) Tetramers
    Srijit Khan, Yanling Liu, Laura M. Ernst, Leslie Y. T. Leung, Patrick Budylowski, Shilan Dong, Paolo Campisi, Evan Jon Propst, Nikolaus Ernst Wolter, Eyal Grunebaum et al. · 2020 · Cells
88. Radiolabeling and cytotoxicity of monoclonal antibody Isatuximab functionalized silver nanoparticles on the growth of multiple myeloma
    Hanan M. El-Shershaby, Nourihan S. Farrag, N. H. Ebeid, Kamel A. Moustafa · 2022 · International Journal of Pharmaceutics
89. HTLV-1 infection of donor-derived T cells might promote acute graft-versus-host disease following liver transplantation
    Chuan Shen, Yiyang Li, Boqian Wang, Zhipeng Zong, Tianfei Lu, Nokuzola Maboyi, Yuxiao Deng, Yongbing Qian, Jianjun Zhang, Xianting Ding et al. · 2022 · Nature Communications
90. TNF-α Regulation of CD38 Expression in Human Airway Smooth Muscle: Role of MAP Kinases and NF-κB
    Joseph Antony Jude, Reynold A. Panettieri, Timothy Francis Walseth, Mathur Kannan · 2010 · Advances in experimental medicine and biology
91. A second‐generation <scp>CD38‐CAR‐T</scp> cell for the treatment of multiple myeloma
    Li, Hongwen, Li, Jing, Wu, Jiazhuo, Shi, Zhuangzhuang, Gao, Yuyang, Song, Wenting, Li, Jiwei, Li, Zhaoming, Zhang, Mingzhi · 2023 · Cancer Medicine
92. CD38 symmetric dimethyl site R58 promotes malignant tumor cell immune escape by regulating the cAMP-GSK3β-PD-L1 axis
    Lin Liang, Chunxue Yue, Wentao Li, Jingqiong Tang, Qian He, Feng Zeng, Jiaying Cao, Siyi Liu, Yan Chen, Xin Li et al. · 2024 · Heliyon
93. Accumulation of CD38 in Hybrid Epithelial/Mesenchymal Cells Promotes Immune Remodeling and Metastasis in Breast Cancer
    Tanvi H. Visal, Recep Bayraktar, Petra den Hollander, Michael A. Attathikhun, Tieling Zhou, Jing Wang, Li Shen, Corina-Elena Minciuna, Meng Chen, Elizve Barrientos-Toro et al. · 2025 · Cancer Research
94. Unveiling the role of NAD glycohydrolase CD38 in aging and age-related diseases: insights from bibliometric analysis and comprehensive review
    Xianghui Zhao, Peiying Lv, Zixing Cai, Jun Dong, Wenxiang Chen, Liang Sun, Ruiyue Yang · 2025 · Frontiers in Immunology
95. NAD+ glycohydrolases-CD38 as a therapeutic target in aging: physiological roles, molecular mechanisms, and future opportunities in anti-aging research
    Jing-Yu Sun, Zhifei Wang, Wenhui Xu, Jun Zhao · 2025 · Biochemical Pharmacology
96. Application of nanobody‑based CAR‑T in tumor immunotherapy (Review)
    Hongjing Liu, Xueping Liu, Xuyan Zhou, Siliang Duan, Xin Huang, Hongxin Fei, Yali Kou · 2025 · International Journal of Molecular Medicine
97. Reproductive Ageing: Current insights and a potential role of NAD in the reproductive health of aging fathers and their children
    Morgan B. Feuz, Darin Nelson, Laura B Miller, Alexie E. Zwerdling, Ralph G. Meyer, Mirella L. Meyer‐Ficca · 2024 · Reproduction
98. Cytomegalovirus reactivation is frequent in multiple myeloma patients treated with daratumumab‐based regimens
    Danilo De Novellis, Raffaele Fontana, Bianca Serio, Emilia Vaccaro, Roberto Guariglia, Denise Morini, Michela Rizzo, Valentina Giudice, Carmine Selleri · 2024 · Cancer Medicine
99. Dual roles of extracellular vesicles in acute lymphoblastic leukemia: implications for disease progression and theranostic strategies
    Mahya Sadat Lajevardi, Mahshad Ashrafpour, Shaden M. H. Mubarak, Behnoosh Rafieyan, Arash Kiani, Effat Noori, Marzieh Roayaei Ardakany, Maryam Montazeri, Niloofar Kouhi Esfahani, Naghmeh Asadimanesh et al. · 2024 · Medical Oncology
100. Nanobodies as probes to investigate purinergic signaling.
     M. Eggers, F. Ruhl, F. Haag, F. Koch-Nolte · 2020 · Biochemical Pharmacology